Artificial intelligence-driven clinical decision support systems for early detection and precision therapy in oral cancer: a mini review
Manoj Kumar Karuppan Perumal,
No information about this author
Remya Rajan Renuka,
No information about this author
Suresh Kumar
No information about this author
et al.
Frontiers in Oral Health,
Journal Year:
2025,
Volume and Issue:
6
Published: April 28, 2025
Oral
cancer
(OC)
is
a
significant
global
health
burden,
with
life-saving
improvements
in
survival
and
outcomes
being
dependent
on
early
diagnosis
precise
treatment
planning.
However,
planning
are
predicated
the
synthesis
of
complicated
information
derived
from
clinical
assessment,
imaging,
histopathology
patient
histories.
Artificial
intelligence-based
decision
support
systems
(AI-CDSS)
provides
viable
solution
that
can
be
implemented
via
advanced
methodologies
for
data
analysis,
better
diagnostic
prognostic
evaluation.
This
review
presents
AI-CDSS
as
promising
through
comprehensive
analysis.
In
addition,
it
examines
current
implementations
facilitate
OC
detection,
staging,
personalized
by
processing
multimodal
machine
learning,
computer
vision,
natural
language
processing.
These
effectively
interpret
results,
identify
critical
disease
patterns
(including
stage,
site,
tumor
dimensions,
histopathologic
grading,
molecular
profiles),
construct
profiles.
approach
allows
reduction
delays
improved
intervention
outcomes.
Moreover,
also
optimizes
plans
basis
unique
parameters,
stages
risk
factors,
providing
therapy.
Language: Английский
Molecular Mechanisms Underlying Anticancer and Anti-Inflammatory Activities of Oridonin in Oral Squamous Cell Carcinoma
BioScientific Review,
Journal Year:
2025,
Volume and Issue:
7(1), P. 124 - 142
Published: May 6, 2025
Background.
Oral
squamous
cell
carcinoma
(OSCC)
constitutes
one
of
the
most
common
pathological
forms
oral
cancers.
Oridonin
is
an
ent-kaurane
diterpenoid
compound
isolated
from
Rabdosia
rubescens.
Recently,
anticancer
potential
has
been
extensively
studied
in
breast,
osteosarcoma,
myeloma,
neuroblastoma,
lymphoma,
pancreatic,
colon,
leukemia,
and
esophageal
The
largely
unexplored
OSCC.
Method.
This
study
aimed
to
provide
insights
into
multifunctional
activities
We
carried
out
extensive
critical
literature
survey
on
research
related
importance
medicinal
plants
various
cancers,
role
as
agents
OSCC
up
2025
using
keywords
apoptotic
proteins,
antitumor
activities,
cycle
arrest,
diterpenoid,
inflammasomes,
Notch
signaling
pathway,
natural
products,
Oridonin,
carcinoma,
cancer
treatment.
Results.
induces
apoptosis
cells
(OCC)
by
regulating
mitochondrial
ROS-mediated
JNK/p38
MAPK,
acting
blocker
at
G2/M
phase
pathways,
increasing
expression
γH2AX.
plays
essential
tumorigenesis
inhibiting
phosphatidylinositol
3-kinase
(PI3K)/protein
kinase
B
(AKT)
pathway.
Blocking
dysregulation
specific
inhibition
NLRP3
inflammasome
are
other
cellular
mechanism
which
can
exhibit
its
activities.
Conclusion.
serve
a
drug
due
involvement
multiple
pathways.
Language: Английский